SG11201810633WA - New fluorescent dyes and their uses as biomarkers - Google Patents
New fluorescent dyes and their uses as biomarkersInfo
- Publication number
- SG11201810633WA SG11201810633WA SG11201810633WA SG11201810633WA SG11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- ffc
- chesterford
- pct
- essex
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B62/00—Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves
- C09B62/02—Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves with the reactive group directly attached to a heterocyclic ring
- C09B62/36—Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves with the reactive group directly attached to a heterocyclic ring to some other heterocyclic ring
- C09B62/365—Specific dyes not provided for in groups C09B62/38 - C09B62/42
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Luminescent Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662402635P | 2016-09-30 | 2016-09-30 | |
| PCT/EP2017/074880 WO2018060482A1 (en) | 2016-09-30 | 2017-09-29 | New fluorescent dyes and their uses as biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810633WA true SG11201810633WA (en) | 2018-12-28 |
Family
ID=60268333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810633WA SG11201810633WA (en) | 2016-09-30 | 2017-09-29 | New fluorescent dyes and their uses as biomarkers |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10385214B2 (enExample) |
| EP (2) | EP3974425B1 (enExample) |
| JP (2) | JP7002478B2 (enExample) |
| KR (2) | KR102582172B1 (enExample) |
| CN (1) | CN109476654B (enExample) |
| AU (2) | AU2017335223B2 (enExample) |
| CA (1) | CA3026019C (enExample) |
| ES (2) | ES2988726T3 (enExample) |
| IL (2) | IL297749B2 (enExample) |
| SG (1) | SG11201810633WA (enExample) |
| WO (1) | WO2018060482A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10385214B2 (en) | 2016-09-30 | 2019-08-20 | Illumina Cambridge Limited | Fluorescent dyes and their uses as biomarkers |
| GB201716931D0 (en) * | 2017-10-16 | 2017-11-29 | Illumina Cambridge Ltd | New fluorescent compounds and their use as biomarkers |
| CN112601825B (zh) * | 2018-07-09 | 2023-11-28 | 青岛华大智造科技有限责任公司 | 核酸测序方法 |
| US11293061B2 (en) | 2018-12-26 | 2022-04-05 | Illumina Cambridge Limited | Sequencing methods using nucleotides with 3′ AOM blocking group |
| NL2023327B1 (en) * | 2019-03-01 | 2020-09-17 | Illumina Inc | Multiplexed fluorescent detection of analytes |
| BR112020026669A2 (pt) * | 2019-03-01 | 2021-09-08 | Illumina Cambridge Limited | Composto de cumarina substituído com amina terciária, nucleotídeos ou oligonucleotídeos, kit, uso dos mesmos, método de sequenciamento e método para sintetizar um composto |
| WO2020178231A1 (en) | 2019-03-01 | 2020-09-10 | Illumina, Inc. | Multiplexed fluorescent detection of analytes |
| IL279674B2 (en) | 2019-03-01 | 2025-04-01 | Illumina Cambridge Ltd | Amine-modified exocyclic coumarins and their use as fluorescent tags |
| MX2022005327A (es) | 2019-11-27 | 2022-08-04 | Illumina Cambridge Ltd | Tintes y composiciones que contienen ciclooctatetraeno.. |
| US11787831B2 (en) | 2020-06-22 | 2023-10-17 | Illumina Cambridge Limited | Nucleosides and nucleotides with 3′ acetal blocking group |
| US11981964B2 (en) | 2020-07-28 | 2024-05-14 | Illumina Cambridge Limited | Substituted coumarin dyes and uses as fluorescent labels |
| US20220195516A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Methods, systems and compositions for nucleic acid sequencing |
| US20220195196A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Alkylpyridinium coumarin dyes and uses in sequencing applications |
| US20220195517A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Long stokes shift chromenoquinoline dyes and uses in sequencing applications |
| US20220195518A1 (en) | 2020-12-22 | 2022-06-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing |
| CN114671842B (zh) * | 2020-12-24 | 2024-05-28 | 郑州思昆生物工程有限公司 | 一种荧光化合物及其制备方法、荧光修饰核苷酸、试剂盒 |
| BR112023024130A2 (pt) | 2021-05-20 | 2024-01-30 | Illumina Cambridge Ltd | Composições e métodos para sequenciamento por síntese |
| US20220403450A1 (en) | 2021-06-03 | 2022-12-22 | Illumina Software, Inc. | Systems and methods for sequencing nucleotides using two optical channels |
| KR20240049214A (ko) | 2021-09-01 | 2024-04-16 | 일루미나, 인코포레이티드 | 가속 염기 호출을 위한 진폭 변조 |
| WO2023107622A1 (en) | 2021-12-10 | 2023-06-15 | Illumina, Inc. | Parallel sample and index sequencing |
| EP4493721A1 (en) | 2022-03-15 | 2025-01-22 | Illumina, Inc. | Parallel sample and index sequencing |
| EP4499862A1 (en) | 2022-03-28 | 2025-02-05 | Illumina, Inc. | Labeled avidin and methods for sequencing |
| US20230313292A1 (en) | 2022-03-29 | 2023-10-05 | Illumina Cambridge Limited | Chromenoquinoline dyes and uses in sequencing |
| US20230332197A1 (en) | 2022-03-31 | 2023-10-19 | Illumina Singapore Pte. Ltd. | Nucleosides and nucleotides with 3' vinyl blocking group |
| WO2023186982A1 (en) | 2022-03-31 | 2023-10-05 | Illumina, Inc. | Compositions and methods for improving sequencing signals |
| WO2023232829A1 (en) | 2022-05-31 | 2023-12-07 | Illumina, Inc | Compositions and methods for nucleic acid sequencing |
| EP4547675A1 (en) | 2022-06-28 | 2025-05-07 | Illumina, Inc. | Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing |
| EP4594428A2 (en) | 2022-09-30 | 2025-08-06 | Illumina, Inc. | Compositions and methods for reducing photo damage during sequencing |
| EP4638795A1 (en) | 2022-12-22 | 2025-10-29 | Illumina, Inc. | Transition-metal catalyst compositions and methods for sequencing by synthesis |
| WO2024137774A1 (en) | 2022-12-22 | 2024-06-27 | Illumina, Inc. | Palladium catalyst compositions and methods for sequencing by synthesis |
| US20240271206A1 (en) | 2022-12-27 | 2024-08-15 | Illumina, Inc. | Methods of sequencing using 3' allyl blocked nucleotides |
| WO2024206407A2 (en) | 2023-03-29 | 2024-10-03 | Illumina, Inc. | Naphthalimide dyes and uses in nucleic acid sequencing |
| US20240327909A1 (en) | 2023-03-30 | 2024-10-03 | Illumina, Inc. | Compositions and methods for nucleic acid sequencing |
| WO2025049700A1 (en) | 2023-08-31 | 2025-03-06 | Illumina, Inc. | Compositions and methods for nucleic acid sequencing |
| WO2025061922A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Methods for sequencing |
| WO2025061942A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Sequencing error identification and correction |
| US20250137048A1 (en) | 2023-10-26 | 2025-05-01 | Illumina, Inc. | 4,5-substituted naphthalimide dyes and uses in nucleic acid sequencing |
| US20250215493A1 (en) | 2023-12-28 | 2025-07-03 | Illumina, Inc. | Nucleotides with enzymatically cleavable 3'-o-glycoside blocking groups for sequencing |
| WO2025184226A1 (en) | 2024-02-28 | 2025-09-04 | Illumina, Inc. | Nucleotides with terminal phosphate capping |
| WO2025188906A1 (en) | 2024-03-08 | 2025-09-12 | Illumina, Inc. | Modified adenosine nucleotides |
| WO2025221895A1 (en) | 2024-04-19 | 2025-10-23 | Illumina, Inc. | Water soluble polymer scaffolds for dye labeling |
| WO2025230914A1 (en) | 2024-04-29 | 2025-11-06 | Illumina, Inc. | Nucleotides with enzyme-triggered self-immolative linkers for sequencing by synthesis |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2411969A1 (de) | 1974-03-13 | 1975-09-25 | Bayer Ag | Farbstofflaser |
| US5302509A (en) | 1989-08-14 | 1994-04-12 | Beckman Instruments, Inc. | Method for sequencing polynucleotides |
| US5846719A (en) | 1994-10-13 | 1998-12-08 | Lynx Therapeutics, Inc. | Oligonucleotide tags for sorting and identification |
| ATE364718T1 (de) | 1997-04-01 | 2007-07-15 | Solexa Ltd | Verfahren zur vervielfältigung von nukleinsäure |
| US6465178B2 (en) | 1997-09-30 | 2002-10-15 | Surmodics, Inc. | Target molecule attachment to surfaces |
| US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
| GB0002310D0 (en) | 2000-02-01 | 2000-03-22 | Solexa Ltd | Polynucleotide sequencing |
| EP1105529B2 (en) | 1998-07-30 | 2013-05-29 | Illumina Cambridge Limited | Arrayed biomolecules and their use in sequencing |
| AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
| US6391937B1 (en) | 1998-11-25 | 2002-05-21 | Motorola, Inc. | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
| US6169185B1 (en) | 1999-02-25 | 2001-01-02 | Day-Glo Color Corp. | Ink jet printing inks |
| US6372813B1 (en) | 1999-06-25 | 2002-04-16 | Motorola | Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays |
| US6664061B2 (en) | 1999-06-25 | 2003-12-16 | Amersham Biosciences Ab | Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| EP1307414A2 (en) | 2000-08-09 | 2003-05-07 | Amersham Biosciences AB | The use and evaluation of a 2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| SI3363809T1 (sl) | 2002-08-23 | 2020-08-31 | Illumina Cambridge Limited | Modificirani nukleotidi za polinukleotidno sekvenciranje |
| PT2119722T (pt) | 2002-08-23 | 2016-12-12 | Illumina Cambridge Ltd | Nucleótidos marcados |
| GB0321306D0 (en) | 2003-09-11 | 2003-10-15 | Solexa Ltd | Modified polymerases for improved incorporation of nucleotide analogues |
| GB0326073D0 (en) | 2003-11-07 | 2003-12-10 | Solexa Ltd | Improvements in or relating to polynucleotide arrays |
| JP2007525571A (ja) | 2004-01-07 | 2007-09-06 | ソレクサ リミテッド | 修飾分子アレイ |
| WO2006120433A1 (en) | 2005-05-10 | 2006-11-16 | Solexa Limited | Improved polymerases |
| GB0517097D0 (en) | 2005-08-19 | 2005-09-28 | Solexa Ltd | Modified nucleosides and nucleotides and uses thereof |
| US8178360B2 (en) | 2006-05-18 | 2012-05-15 | Illumina Cambridge Limited | Dye compounds and the use of their labelled conjugates |
| US9085698B2 (en) | 2011-09-23 | 2015-07-21 | Illumina Cambridge Limited | Dyes for labelling molecular ligands |
| PT3623481T (pt) | 2011-09-23 | 2021-10-15 | Illumina Inc | Composições para sequenciação de ácidos nucleicos |
| US9012022B2 (en) | 2012-06-08 | 2015-04-21 | Illumina, Inc. | Polymer coatings |
| WO2014135223A1 (en) | 2013-03-08 | 2014-09-12 | Illumina Cambridge Ltd | Rhodamine compounds and their use as fluorescent labels |
| WO2014139596A1 (en) | 2013-03-15 | 2014-09-18 | Illumina Cambridge Limited | Modified nucleosides or nucleotides |
| US10385214B2 (en) | 2016-09-30 | 2019-08-20 | Illumina Cambridge Limited | Fluorescent dyes and their uses as biomarkers |
-
2017
- 2017-09-28 US US15/719,216 patent/US10385214B2/en active Active
- 2017-09-29 EP EP21195809.5A patent/EP3974425B1/en active Active
- 2017-09-29 AU AU2017335223A patent/AU2017335223B2/en active Active
- 2017-09-29 IL IL297749A patent/IL297749B2/en unknown
- 2017-09-29 WO PCT/EP2017/074880 patent/WO2018060482A1/en not_active Ceased
- 2017-09-29 SG SG11201810633WA patent/SG11201810633WA/en unknown
- 2017-09-29 EP EP17794669.6A patent/EP3519410B1/en active Active
- 2017-09-29 KR KR1020227041740A patent/KR102582172B1/ko active Active
- 2017-09-29 JP JP2018566882A patent/JP7002478B2/ja active Active
- 2017-09-29 CA CA3026019A patent/CA3026019C/en active Active
- 2017-09-29 ES ES21195809T patent/ES2988726T3/es active Active
- 2017-09-29 KR KR1020187037385A patent/KR102473054B1/ko active Active
- 2017-09-29 IL IL263871A patent/IL263871B2/en unknown
- 2017-09-29 ES ES17794669T patent/ES2914688T3/es active Active
- 2017-09-29 CN CN201780042127.1A patent/CN109476654B/zh active Active
-
2019
- 2019-08-13 US US16/539,606 patent/US10844225B2/en active Active
-
2020
- 2020-11-17 US US16/950,705 patent/US11370920B2/en active Active
-
2021
- 2021-12-27 JP JP2021212730A patent/JP2022050495A/ja not_active Withdrawn
-
2022
- 2022-11-07 AU AU2022268273A patent/AU2022268273B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201810633WA (en) | New fluorescent dyes and their uses as biomarkers | |
| SG11201810611YA (en) | Coumarin compounds and their uses as fluorescent labels | |
| SG11201908820VA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201900746RA (en) | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions | |
| SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
| SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
| SG11201901747VA (en) | Inhibitors of cellular metabolic processes | |
| SG11201809539RA (en) | Covalently modified surfaces, kits, and methods of preparation and use | |
| SG11201900883UA (en) | Combination treatment for hematological cancers | |
| SG11201906386XA (en) | Combination therapy involving diaryl macrocyclic compounds | |
| SG11201901658PA (en) | Beta-lactamase inhibitor compounds | |
| SG11201900200XA (en) | Tgfb antibodies, methods, and uses | |
| SG11201908743SA (en) | Methods and compositions for modulation of immune cells | |
| SG11201408451WA (en) | Use of vacuum chucks to hold a wafer or wafer sub-stack | |
| SG11201906413XA (en) | Exposure apparatus | |
| SG11201807596YA (en) | Gitr antibodies, methods, and uses | |
| SG11201908456VA (en) | Linker units and molecular constructs comprising same | |
| SG11201908091QA (en) | Aqueous anti-pd-l1 antibody formulation | |
| SG11201811062XA (en) | Cysteine engineered fibronectin type iii domain binding molecules | |
| SG11202000331YA (en) | Therapeutic modulators of the reverse mode of atp synthase | |
| SG11201901873PA (en) | Tablet compositions | |
| SG11201903091VA (en) | Quinoxaline compounds as type iii receptor tyrosine kinase inhibitors | |
| SG11201903348UA (en) | Therapeutic compounds and methods of use thereof | |
| SG11201900589PA (en) | Methods for gynecologic neoplasm diagnosis |